This website is intended for healthcare professionals only

Trending Topic

16 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

Hypertension is the leading modifiable risk factor for global cardiovascular disease, responsible for an estimated 10.8 million deaths and more than 200 million disability-adjusted life years annually.1 Despite the availability of effective pharmacological and lifestyle interventions, prevalence continues to rise, particularly in low- and middle-income countries (LMICs), where over three-quarters of all cases now occur.2 The condition’s […]

Phosphate overload accelerates vascular aging in uremic patients

Mario Cozzolino, Maurizio Gallieni, Andrea Galassi, Claudia Brambilla, Diego Brancaccio
< 1 min
Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Published Online: Jul 25th 2018 Heart International 2006;2(1):6-11
Select a Section…
1

Abstract

Overview

Vascular calcification is a very common event in patients affected by diabetes and
chronic kidney disease (CKD). Recently, it has been well documented that abnormalities in mineral
and bone metabolism in CKD patients are associated with increased morbidity and mortality.
Elevated serum phosphate and calcium-phosphate product levels play an important role in
the pathogenesis of vascular mineralization in uremic patients and also appear to be associated
with increased cardiovascular mortality. Together with classical passive precipitation of calciumphosphate
in soft tissues, during the last decade it has been demonstrated that inorganic phosphate
may cause extraskeletal calcification directly through a real “ossification” of the tunica
media in the vasculature of CKD patients. Therefore, control of phosphate retention is now an
even more crucial target of treatment in patients affected by chronic kidney disease. (Heart International
2006; 2: 6-11)

Keywords

Vascular calcification, Phosphate, Chronic kidney disease

2

Article Information

Correspondence

Mario Cozzolino, MD, Renal Unit, Ospedale San Paolo, Azienda Ospedale San Paolo, Via A. di Rudinì, 8, 20142 Milano – Italy, mariocozzolino@hotmail.com

3

Further Resources

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Download as PDF
Close Popup